BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 886757)

  • 1. [Effect of drugs used in the treatment of thrombotic and hemorrhagic conditions on the erythrocyte aggregation].
    Lakin KM; Ovnatanova MS
    Kardiologiia; 1977 May; 17(5):79-83. PubMed ID: 886757
    [No Abstract]   [Full Text] [Related]  

  • 2. Absence of in vitro cross-reaction of pentasaccharide with the plasma heparin-dependent factor of twenty-five patients with heparin-associated thrombocytopenia.
    Elalamy I; Lecrubier C; Potevin F; Abdelouahed M; Bara L; Marie JP; Samama M
    Thromb Haemost; 1995 Nov; 74(5):1384-5. PubMed ID: 8607131
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacological and clinical studies with Lomoparan, a low molecular weight glycosaminoglycan.
    Nurmohamed MT; Fareed J; Hoppensteadt D; Walenga JM; ten Cate JW
    Semin Thromb Hemost; 1991; 17 Suppl 2():205-13. PubMed ID: 1948091
    [No Abstract]   [Full Text] [Related]  

  • 4. Anticoagulant and thrombolytic drugs. I. Patho-physiological and pharmacological aspects.
    Ogston D; Douglas AS
    Drugs; 1971; 1(3):228-46. PubMed ID: 4256645
    [No Abstract]   [Full Text] [Related]  

  • 5. Chemical characteristics and antithrombotic effect of chondroitin sulfates from sturgeon skull and sturgeon backbone.
    Gui M; Song J; Zhang L; Wang S; Wu R; Ma C; Li P
    Carbohydr Polym; 2015 Jun; 123():454-60. PubMed ID: 25843879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of proteoglycans (PG) and glycosaminoglycans (GAG) on ADP-, collagen- and thrombin-induced platelet aggregation.
    Klein K; Sinzinger H; Silberbauer K; Stachelberger H; Leithner C
    Artery; 1980; 8(5):410-5. PubMed ID: 6783013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative evaluation of the effectiveness of drugs influencing the microrheological properties of the blood in the treatment of retinal vein thrombosis].
    Mukha AI; Davydova NG; Konde LA; Tartakovskaia AI
    Vestn Oftalmol; 1988; 104(3):60-3. PubMed ID: 3176249
    [No Abstract]   [Full Text] [Related]  

  • 8. [New antithrombotic drugs (excluding plasminogen activators].
    Lecompte T
    Arch Mal Coeur Vaiss; 2001 Nov; 94(11 Suppl):1225-32. PubMed ID: 11794963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of platelet-inhibitory drugs, anticoagulants, and thrombolytic agents.
    Mehta JL; Kitchens CS
    Cardiovasc Clin; 1987; 18(1):163-79. PubMed ID: 3111692
    [No Abstract]   [Full Text] [Related]  

  • 10. Dual effects of sulfated D-galactans from the red algae Botryocladia occidentalis preventing thrombosis and inducing platelet aggregation.
    Farias WR; Nazareth RA; MourĂ£o PA
    Thromb Haemost; 2001 Dec; 86(6):1540-6. PubMed ID: 11776325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coagulation for cardiologists.
    Wessler S; Gitel SN
    Am Heart J; 1978 Dec; 96(6):811-23. PubMed ID: 362880
    [No Abstract]   [Full Text] [Related]  

  • 12. Mode of action of heparin and related drugs.
    Hemker HC; Beguin S
    Semin Thromb Hemost; 1991; 17 Suppl 1():29-34. PubMed ID: 1648791
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of ilexonin A on platelet function and ultrastructure].
    Wang Z; Du JX
    Zhong Xi Yi Jie He Za Zhi; 1985 Apr; 5(4):232-4, 197. PubMed ID: 3158445
    [No Abstract]   [Full Text] [Related]  

  • 14. [Complex compound of heparin and glutamic acid: synthesis and effect on hemostasis parameters in vitro and in vivo].
    Liapina LA; Ziadetdinova GA
    Izv Akad Nauk Ser Biol; 2001; (1):82-6. PubMed ID: 11236584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drugs and herbal remedies that affect blood clotting.
    Wynn RL; Bergman SA
    Gen Dent; 2002; 50(6):484-8, 490. PubMed ID: 12572177
    [No Abstract]   [Full Text] [Related]  

  • 16. [Anticoagulant, fibrinolytic and antithrombotic effects of the heparin-insulin complex].
    Liapina LA; Pastorova VE
    Izv Akad Nauk Ser Biol; 2002; (6):710-3. PubMed ID: 12561334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged bleeding time induced by anticoagulant glycosaminoglycans in dogs is associated with the inhibition of thrombin-induced platelet aggregation.
    Kitazato K; Kitazato KT; Sasaki E; Minamiguchi K; Nagase H
    Thromb Res; 2003; 112(1-2):83-91. PubMed ID: 15013278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of various proteins on erythrocyte aggregation effected by proteoglycans].
    Bychkov SM; Kuz'mina SA
    Biull Eksp Biol Med; 1991 Jun; 111(6):605-6. PubMed ID: 1716504
    [No Abstract]   [Full Text] [Related]  

  • 19. [Inhibitory actions of acidic polymucosaccharides and sulphuric polysaccharides on platelet aggregation (author's transl)].
    Asada T; Igarashi N; Mukoyama H; Shiba T
    Nihon Ketsueki Gakkai Zasshi; 1979 Jun; 42(3):548-9. PubMed ID: 495015
    [No Abstract]   [Full Text] [Related]  

  • 20. [Current state of anticoagulant and fibrinolytic therapy].
    Hladovec J
    Cas Lek Cesk; 1971 Oct; 110(42):969-75. PubMed ID: 5114558
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.